Trial Condition(s):

Hypertension

Study on safety, tolerability and pharmacokinetics of one tablet Adalat OROS 30 or of one tablet Nifedipine Sandoz retard 30 after an overnight fasting or immediately after an American breakfast in healthy male volunteers

Bayer Identifier:

11819

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2004-004125-10

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
28
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Adalat Oros (Nifedipine, BAYA1040)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

SocraTec R&D Clinical Ward

Erfurt, Germany, 99084

Status
Completed
 

For details, please refer to trial results

Additional Information